FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits


Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.



Source

Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews
Health

Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food […]

Read More
Taking on Goliath: Brain surgeon’s clash with UnitedHealthcare shows insurer’s hardball tactics
Health

Taking on Goliath: Brain surgeon’s clash with UnitedHealthcare shows insurer’s hardball tactics

Dr. Catherine Mazzola, a pediatric neurosurgeon, runs a practice she says is in serious jeopardy because of recent moves by UnitedHealth Group. Zach Gross for NBC News Dr. Catherine Mazzola, a pediatric neurosurgeon, runs a practice in New Jersey that treats low-income children on Medicaid. Since 2008, she has cared for boys and girls with cerebral palsy, […]

Read More
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
Health

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic […]

Read More